In-house roundup: German injunction reform; fintech partnership challenges; plausibility data conundrums

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house roundup: German injunction reform; fintech partnership challenges; plausibility data conundrums

Drugs

Managing IP rounds up the latest news and analysis from patent-focused businesses on German injunctions, fintech partnerships and plausibility conundrums

Drugs

German injunction reform: end injunction gap first say patent holders

Siemens, Nokia, the VDMA and others weigh in on government talks around automatic injunctions and agree that more judges and perhaps a lower hurdle to stay infringement proceedings are needed at the Federal Patent Court. Read more... 

Pharma companies uncertain on data needed for plausibility claims

Drug company lawyers say it is tricky determining the right kind and amount of data to support a claim because courts and examiners have different expectations of sufficiency to determine plausibility. Read more... 

Fintech partnership surge exacerbates negotiation and trade secret challenges

In-house counsel at MasterCard, American Express, MIAX and elsewhere explain how their growing number of fintech partnerships is affecting negotiations and increasing the risk of trade secret and patent litigation. Read more... 

Sign up to receive more content like this in Patent Strategy’s weekly newsletter.



more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article